Chiropractors in Nashwauk, MN Accepting Medicare
2 Chiropractors found. Showing 1 - 2
 Debra Ward Meadows Dc Chiropractor Medicare: Medicare Enrolled Practice Location: 113 First Street, Nashwauk, MN 55769 Phone: 218-885-2070 Fax: 218-885-2070 |
 Mrs. Debra Ann Meadows, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 113 First Street, Nashwauk, MN 55769 Phone: 218-885-2070 Fax: 218-885-2070 |
News Archive
UK IPO rejects revocation action by Biogene against Enigma's patents
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced that the UK Intellectual Property Office (IPO) has rejected a revocation action brought by Biogene against three patents licensed exclusively to Enigma by the Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence.
Recession leads to closure of long-term care facilities: Study
The 2008-2009 recession led to smaller cost increases at many long-term care facilities and forced some to close altogether, according to a study released today by Prudential Financial Inc. (NYSE). The bi-annual report, 2010 Long-Term Care Cost Study, measures trends in costs associated with the major forms of long-term care services. And, for the first time, the research includes consumer views that measure sentiment around the cost of services and levels of awareness and concern about the future need for long-term care and how to fund it.
Mouthguards can help reduce injuries in student athletes
As student athletes prepare to return to school, it's crucial they wear protective gear, like mouthguards, even when playing sports not usually associated with contact. A properly fitted mouthguard can help save your child's smile and keep them off the injured list.
Nurse-led initiatives reduce length of stay, improve patient outcomes in Philadelphia hospitals
Recent nurse-led initiatives addressing some of critical care's most pressing challenges resulted in shorter average lengths of stay and other positive patient and fiscal outcomes in seven Philadelphia-area hospitals.
pSivida announces FDA Priority Review status for Iluvien NDA
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has been notified that the U.S. Food and Drug Administration (FDA) has granted Priority Review status for the New Drug Application (NDA) filed for Iluvien for the treatment diabetic macular edema (DME).
› Verified 6 days ago